Epithelial carcinoma of the ovary or Ovarian cancer is one of the most common gynecologic diseases. It is serious and has a very high mortality rate. It is the fifth most frequent cause of cancer death in women. It is most common in women above fifty years of age. The cancer can appear in younger women too. It is seen that women having genetic predisposition are at greater risk. Clinical statistics also show less cases of this malignancy in women using contraceptive medication. Women who have had early pregnancy or have more children also seem to be at a lower risk factor.

Prognostic factors are used to predict the likely course of ovarian cancer. Stage is the only unanimously acknowledged prognostic factor for patients with ovarian cancer. In case of advanced stage patients, volume of residual disease is considered as a diagnostic factor. To begin a prognosis and establish treatment, the physician needs to know the cell type, stage, and grade of the disease. Other factors that may be important include the patient?s age, histopathologic grade, DNA ploidy, Peritoneal fluid cytology and CA125.

The International Federation of Gynecology and Obstetrics (FIGO), has created standards for the staging of gynecological cancers. Both surgical and pathological findings are taken into account, hence it is called surgicopathologic.

Most ovarian cancer symptoms are seen only in the late stages of the disease. Ovarian cancer is treated with surgery to remove the cancerous cells. This is followed by chemotherapy. It is recommended that people experiencing vaginal bleeding, uncharacteristic period cycles, or intestinal problems should see a physician right away, so that such cases can be detected at the earliest.

Unfortunately, like most of the cancers, the exact cause of ovarian cancer is not known. It is also difficult to find precise information due to contradictory studies.